OtherBASIC SCIENCE INVESTIGATIONS
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe and Koen Van Laere
Journal of Nuclear Medicine May 2009, 50 (5) 818-822; DOI: https://doi.org/10.2967/jnumed.108.060756
Michel Koole
Dewi M. Lewis
Christopher Buckley
Natalie Nelissen
Mathieu Vandenbulcke
David J. Brooks
Rik Vandenberghe

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe, Koen Van Laere
Journal of Nuclear Medicine May 2009, 50 (5) 818-822; DOI: 10.2967/jnumed.108.060756
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe, Koen Van Laere
Journal of Nuclear Medicine May 2009, 50 (5) 818-822; DOI: 10.2967/jnumed.108.060756
Jump to section
Related Articles
Cited By...
- Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease
- An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N
- Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand 18F-FE-PE2I in Human Subjects
- Increased midlife triglycerides predict brain {beta}-amyloid and tau pathology 20 years later
- SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0
- Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
- Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
- 18F-ML-10, a PET Tracer for Apoptosis: First Human Study
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease